ATE159029T1 - Phosphonsäurederivate, verfahren zur herstellung und ihre verwendung - Google Patents

Phosphonsäurederivate, verfahren zur herstellung und ihre verwendung

Info

Publication number
ATE159029T1
ATE159029T1 AT92109769T AT92109769T ATE159029T1 AT E159029 T1 ATE159029 T1 AT E159029T1 AT 92109769 T AT92109769 T AT 92109769T AT 92109769 T AT92109769 T AT 92109769T AT E159029 T1 ATE159029 T1 AT E159029T1
Authority
AT
Austria
Prior art keywords
phosphonic acid
isobutyl
production
acid derivatives
unsubstituted
Prior art date
Application number
AT92109769T
Other languages
English (en)
Inventor
Mitsuhiro Wakimasu
Masaaki Mori
Akira Kawada
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ATE159029T1 publication Critical patent/ATE159029T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT92109769T 1991-06-13 1992-06-10 Phosphonsäurederivate, verfahren zur herstellung und ihre verwendung ATE159029T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP14209991 1991-06-13
JP4089111A JPH05105698A (ja) 1991-06-13 1992-04-09 ホスホン酸誘導体、その製造法および用途

Publications (1)

Publication Number Publication Date
ATE159029T1 true ATE159029T1 (de) 1997-10-15

Family

ID=26430544

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92109769T ATE159029T1 (de) 1991-06-13 1992-06-10 Phosphonsäurederivate, verfahren zur herstellung und ihre verwendung

Country Status (6)

Country Link
US (2) US5330978B1 (de)
EP (1) EP0518299B1 (de)
JP (1) JPH05105698A (de)
AT (1) ATE159029T1 (de)
CA (1) CA2071106A1 (de)
DE (1) DE69222570T2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9300048D0 (en) * 1993-01-04 1993-03-03 Wellcome Found Endothelin converting enzyme inhibitors
EP0618224A1 (de) * 1993-03-30 1994-10-05 Merrell Dow Pharmaceuticals Inc. Phosophonomethyldipeptide
US5608078A (en) * 1993-03-30 1997-03-04 Merrell Pharmaceuticals Inc. Phosphonomethyldipeptides and process for preparation thereof
WO1994028012A1 (en) * 1993-05-28 1994-12-08 Warner-Lambert Company Hydroxamate inhibitors of endothelin converting enzyme
FR2707089B1 (fr) * 1993-06-30 1995-08-18 Adir Nouveaux dérivés d'acide phosphonique, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
IT1274673B (it) * 1994-04-14 1997-07-24 Zambon Spa Derivati dell'acido fosfonico utili nel trattamento delle malattie car.iovascolari
US5658902A (en) * 1994-12-22 1997-08-19 Warner-Lambert Company Quinazolines as inhibitors of endothelin converting enzyme
US5958905A (en) 1996-03-26 1999-09-28 Texas Biotechnology Corporation Phosphoramidates, phosphinic amides and related compounds and the use thereof to modulate the activity of endothelin
WO1998042308A1 (fr) * 1997-03-25 1998-10-01 Kao Corporation Agents de prevention du vieillissement de la peau
JP3973748B2 (ja) 1998-01-14 2007-09-12 花王株式会社 発毛抑制剤
DE60135560D1 (de) * 2000-07-19 2008-10-09 Novartis Ag Valsartan salze
US9078808B2 (en) * 2009-03-26 2015-07-14 Warsaw Orthopedic, Inc. Device to deliver magnesium in PEG formulation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4379146A (en) * 1981-02-17 1983-04-05 Merck & Co., Inc. Substituted phosphonamides as antihypertensives
US4432972A (en) * 1981-08-03 1984-02-21 E. R. Squibb & Sons, Inc. Phosphonamidate compounds

Also Published As

Publication number Publication date
JPH05105698A (ja) 1993-04-27
CA2071106A1 (en) 1992-12-14
US5330978A (en) 1994-07-19
EP0518299B1 (de) 1997-10-08
US5330978B1 (en) 1996-06-18
USRE35886E (en) 1998-09-01
EP0518299A3 (en) 1993-04-07
DE69222570D1 (de) 1997-11-13
EP0518299A2 (de) 1992-12-16
DE69222570T2 (de) 1998-02-12

Similar Documents

Publication Publication Date Title
ATE163008T1 (de) Cyclische iminoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
ATE134998T1 (de) Diphenylmethanderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
DE69027440T2 (de) Bizyklische pyrimidinderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung
DE69019111T2 (de) Ascorbinsäure-Tocopheryl-Phosphatdiester zur Hemmung der Maillard-Reaktion.
ES2070994T3 (es) Profarmaco de dopamina.
US5330978B1 (en) Phosphonic acid derivatives and use thereof
ATE71083T1 (de) L-dopa-derivate oder ihre saeureadditionssalze, verfahren zu ihrer herstellung und ihre verwendung.
ATE268752T1 (de) Aralkyl-1,2-diaminen mit calcimimetischer wirkung und verfahren zu ihrer herstellung
DE68908145D1 (de) Verwendung von l-carnitinderivaten zur herstellung eines arzneimittels zur therapeutischen behandlung von peripheren neuropathien.
ES2053668T3 (es) Derivados de poliamina como agentes antineoplasicos.
ATE124408T1 (de) Heterozyklische aminderivate, deren herstellung und deren verwendung.
ATE135573T1 (de) Verwendung von indazol-methoxyalkansäure zur herstellung eines arzneimittels zur behandlung von autoimmunkrankheiten
EP0354568A3 (de) Catechol-Derivate
ATE41659T1 (de) Benzothiazepinderivate, verfahren zur herstellung und pharmazeutische zusammensetzungen.
NO178025C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive (benzhydryloksyetylpiperidyl)alifatiske syrederivater
DE3762969D1 (de) Piperazinverbindungen, verfahren zu ihrer herstellung, pharmazeutische zusammensetzung und verwendung.
FI891155A (fi) Menetelmä terapeuttisesti käyttökelpoisten 4,5,6,7-tetrahydroisotiatsolo/4,5-c/pyridiini-johdannaisten ja niiden isomeerien ja happoadditiosuolojen valmistamiseksi
HUT52478A (en) Process for producing glycerin derivatives and pharmaceutical compositions comprising same
DE3767533D1 (de) D-nor-7-ergolinderivate, verfahren zu ihrer herstellung, pharmazeutische zubereitung und verwendung.
NO963374L (no) Substituerte 4H-pyraner
ATE95177T1 (de) Naphthothiazepin-derivate und verfahren zu ihrer herstellung.
IT1229846B (it) Esteri di catecolammine.
DE3580685D1 (de) Benzoxathiin-derivate, verfahren zu deren herstellung und pharmazeutische zusammenstellungen.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties